The "D-Mannose - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for D-Mannose was estimated at US$830.8 Million in 2023 and is ...
D-mannose did not reduce the proportion of women with recurrent urinary tract infection (UTI), the randomized, placebo-controlled MERIT trial showed. Over the 6-month study period, 51% of women taking ...
A natural sugar used to treat recurring urinary tract infections (rUTIs) did not reduce future episodes, outpatient visits, the use of antibiotics, or symptoms compared with a placebo, according to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback